Data / Form D filings / AXOGEN CORP
AXOGEN CORP: Form D filings
AXOGEN CORP, a biotechnology company in Alachua, FL, filed 6 Form D notices with the SEC between 2009 and 2011. The latest, on June 15, 2011, reports $3 million sold of a $5.5 million offering to 13 investors.
Find out what AXOGEN CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13859 PROGRESS BLVD, SUITE 100, Alachua, FL, 32615
- Phone
- (386) 462-6817
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2006
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1358347
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2011 | Amendment | $5,500,000 | $3,000,000 | $2,500,000 | 13 | May 3, 2011 | sec.gov |
| May 20, 2011 | New notice | $500,000 | $500,000 | $0 | 1 | May 3, 2011 | sec.gov |
| Jan 12, 2011 | Amendment | $3,700,000 | $3,697,545 | $2,455 | 11 | Jun 11, 2010 | sec.gov |
| Jun 25, 2010 | New notice | $2,000,000 | $1,100,000 | $900,000 | 8 | Jun 11, 2010 | sec.gov |
| Jan 22, 2010 | New notice | $4,700,992 | $3,360,993 | $1,339,999 | 8 | Jan 7, 2010 | sec.gov |
| Sep 10, 2009 | New notice | $2,622,234 | $2,622,234 | $0 | 4 | Sep 1, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Engels | Executive Officer | |
| John Harper | Director | |
| Brad Hedger | Executive Officer | |
| Gerard Platerink | Director | |
| John McCallum | Director | |
| Joe Mandato | Director | |
| Karen Zaderej | Executive Officer, Director | |
| Jamie Grooms | Director | |
| Mark Gold | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Jun 13, 2011 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AXOGEN CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.